Evaluation of the Effect of Injectable Platelet-Rich Fibrin on Peri-Implant Soft Tissue Phenotype

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

An inadequate amount of peri-implant soft tissue results in more plaque accumulation around the implants, peri-implant mucositis, marginal bone loss, mucosal recession, and/or attachment loss. In the literature, there are studies evaluating the application of injectable platelet-rich fibrin to the gingiva and oral mucosa around teeth, but injectable platelet-rich fibrin application around implants has not been encountered. This study aimed to evaluate the effect of subgingival and submucosal application of injectable platelet-rich fibrin on peri-implant soft tissue phenotype in patients with inadequate peri-implant soft tissue phenotype.The study will include 80 systemically healthy and non-smoking patients/implants older than 18 years of age with insufficient peri-implant keratinized mucosa width and mucosal thickness who applied to Kütahya University of Health Sciences, Faculty of Dentistry, Department of Periodontology. There are two study groups according to peri-implant mucosa phenotype: Thin phenotype and thick phenotype. All patients will undergo the same procedure of injectable platelet-rich fibrin application

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• be over 18 years old

• The patient does not have any systemic disease

• Patients who do not smoke or who smoke less than 10 cigarettes

• Peri-implant keratinized mucosa width less than 2 mm

• Peri-implant mucosal thickness less than 2 mm

Locations
Other Locations
Turkey
Kütahya Health Sciences University Faculty of Dentistry
RECRUITING
Kütahya
Contact Information
Primary
Berceste Güler Ayyıldız
berceste.guler@ksbu.edu.tr
+05059359207
Backup
Seyma Eken
seyma.eken@ksbu.edu.tr
05518489820
Time Frame
Start Date: 2022-12-15
Estimated Completion Date: 2026-04-15
Participants
Target number of participants: 80
Treatments
Other: Thin phenotype
Mucosa thickness is less than 1 mm and the visibility of the probe in the sulcus is high.
Other: Thick phenotype
Mucosa thickness is greater than 1 mm and visibility of the probe in the sulcus is low.
Related Therapeutic Areas
Sponsors
Leads: Kutahya Health Sciences University

This content was sourced from clinicaltrials.gov